Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,276 | -7,167 | -4,637 | -2,566 | -5,335 |
| Depreciation Amortization | 1,867 | 1,410 | 929 | 445 | 2,246 |
| Accounts receivable | -1,991 | -197 | 53 | -1,099 | 1,308 |
| Accounts payable and accrued liabilities | 465 | -578 | -800 | 424 | 2,465 |
| Other Working Capital | -3,823 | -596 | -971 | -2,725 | 4,243 |
| Other Operating Activity | 4,621 | 2,807 | 2,024 | 1,530 | -955 |
| Operating Cash Flow | $-6,137 | $-4,321 | $-3,402 | $-3,991 | $3,972 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -836 | -839 | -747 | -668 | -2,872 |
| Investing Cash Flow | $-836 | $-839 | $-747 | $-668 | $-2,872 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -146 | -108 | -74 | N/A | N/A |
| Common Stock Issued | 253 | 252 | 252 | 12 | 85 |
| Common Stock Repurchased | -634 | -634 | -634 | -602 | -74 |
| Financing Cash Flow | $-527 | $-490 | $-456 | $-590 | $11 |
| Beginning Cash Position | 10,118 | 10,118 | 10,118 | 10,118 | 9,007 |
| End Cash Position | 2,618 | 4,468 | 5,513 | 4,869 | 10,118 |
| Net Cash Flow | $-7,500 | $-5,650 | $-4,605 | $-5,249 | $1,111 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,137 | -4,321 | -3,402 | -3,991 | 3,972 |
| Capital Expenditure | -836 | -839 | -747 | -668 | -2,872 |
| Free Cash Flow | -6,973 | -5,160 | -4,149 | -4,659 | 1,100 |